Latest Articles

Publication Date
Daniella Karagach Compares Robert Irwin to This Previous “DWTS” Contestant Who 'Won Everyone's Hearts' (Exclusive) - Yahoo News Canada

Daniella Karagach Compares Robert Irwin to This Previous “DWTS” Contestant Who 'Won Everyone's Hearts' (Exclusive) Yahoo News Canada

Published: June 3, 2025, 9:14 p.m.
Daniella Karagach Compares Robert Irwin to This Previous “DWTS” Contestant Who 'Won Everyone's Hearts' (Exclusive) - Yahoo

Daniella Karagach Compares Robert Irwin to This Previous “DWTS” Contestant Who 'Won Everyone's Hearts' (Exclusive) Yahoo

Published: June 3, 2025, 9:14 p.m.
Julianne Hough Celebrates the 20th Anniversary of ‘Dancing With the Stars’ - EntertainmentNow

Julianne Hough Celebrates the 20th Anniversary of ‘Dancing With the Stars’ EntertainmentNow

Published: June 3, 2025, 1:05 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace

Published: June 2, 2025, 11:48 p.m.
Haley Pullos’ Latest Post Has Fans Begging For Her General Hospital Return - Soap Hub

Haley Pullos’ Latest Post Has Fans Begging For Her General Hospital Return Soap Hub

Published: June 2, 2025, 7:49 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - GlobeNewswire

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial GlobeNewswire

Published: June 2, 2025, 6:32 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo Finance

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo Finance

Published: June 2, 2025, 6:30 p.m.
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Yahoo

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial Yahoo

Published: June 2, 2025, 6:30 p.m.
Molecular Testing in Ovarian and Endometrial Cancer: Evolving Approaches and Best Practices - OncLive

Molecular Testing in Ovarian and Endometrial Cancer: Evolving Approaches and Best Practices OncLive

Published: May 30, 2025, 3:48 p.m.
Proteomics International Laboratories Ltd (ASX:PIQ) New Blood Test For Endometriosis Moves Closer to Market - ABN Newswire

Proteomics International Laboratories Ltd (ASX:PIQ) New Blood Test For Endometriosis Moves Closer to Market ABN Newswire

Published: May 30, 2025, 2:43 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!